Don’t use remdesivir in hospitalized COVID-19 patients, WHO says

LONDON — Gilead's remdesivir should not be used for patients hospitalized with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday. Read More

from Canoe https://ift.tt/2ISRXoQ